Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination
Go back to Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination| (NASDAQ: CMND) | Delayed: 0.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.81 | 52 Week High | $ | |||
| Open | $0.81 | 52 Week Low | $ | |||
| Day High | $0.81 | P/E | N/A | |||
| Day Low | $0.81 | EPS | $ | |||
| Volume | 52,852 | |||||
| (NASDAQ: PLRZ) | Delayed: 10.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.78 | 52 Week High | $ | |||
| Open | $10.78 | 52 Week Low | $ | |||
| Day High | $10.78 | P/E | N/A | |||
| Day Low | $10.78 | EPS | $ | |||
| Volume | 17 | |||||
